LONDON, Sept. 16, 2022 /PRNewswire/ -- BenevolentAI ("BenevolentAI" or the "Company") (EuronextAmsterdam:BAI), a leading, clinical-stage AI-enabled drug discovery company, is pleased to announce the full agenda for its upcoming analyst/investor event and interim results being held in London between 14:00 – 17:00 BST (09:00 – 12:00 ET) on Tuesday, 27 September 2022.
Read more at prnewswire.comBenevolentAI Group: Analyst / Investor Event and Interim Results
PR Newswire - Press Release
All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here